Celgene (CELG) option implied volatility decreases on Bristol-Myers (BMY) acquisition

Celgene (NASDAQ: CELG) January call option implied volatility is at 24, February is at 20; compared to its 52-week range of 22 to 57 after Bristol-Myers (BMY) to acquires for equity value of approx. $74B. Call put ratio 1 call to 1.9 puts.

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 3.9 calls to 1 put with a focus on 1600 contracts of October 2 weekly 24 calls into quarter results
• Vail Resorts (MTN) call put ratio 1 call to 4.4 puts with a focus on October puts into quarter results
• Sandisk (SNDK) call put ratio 1.8 calls to 1 put with a focus on October 2 weekly calls